A robust, good manufacturing practice–compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A robust, good manufacturing practice–compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy

Published:2016-10 Issue:10 Volume:18 Page:1312-1324
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Alsuliman Abdullah,Appel Stanley H.,Beers David R.,Basar Rafet,Shaim Hila,Kaur Indresh,Zulovich Jane,Yvon Eric,Muftuoglu Muharrem,Imahashi Nobuhiko,Kondo Kayo,Liu Enli,Shpall Elizabeth J.,Rezvani Katayoun

Funder

ALSFindingACure

ALSAssociation

Rizzuto Foundation

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference48 articles.

1. From vanilla to 28 flavors: multiple varieties of T regulatory cells;Shevach;Immunity,2006

2. Regulatory T cells, tumour immunity and immunotherapy;Zou;Nat Rev Immunol,2006

3. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells;Fontenot;Nat Immunol,2003

4. Control of regulatory T cell development by the transcription factor Foxp3;Hori;Science,2003

5. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation;Edinger;Nat Med,2003

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical applications of immunosequencing;Current Research in Translational Medicine;2024-09

2. Clinical grade multiparametric cell sorting and gene-marking of regulatory T cells;Cytotherapy;2024-07

3. A phase 1 proof-of-concept study evaluating safety, tolerability, and biological marker responses with combination therapy of CTLA4-Ig and interleukin-2 in amyotrophic lateral sclerosis;Frontiers in Neurology;2024-06-10

4. Peripheral Immune Cells Contribute to the Pathogenesis of Alzheimer’s Disease;Molecular Neurobiology;2024-06-06

5. Pharmacometabolomics applied to low‐dose interleukin‐2 treatment in amyotrophic lateral sclerosis;Annals of the New York Academy of Sciences;2024-05-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3